马钢(00323.HK)控股股东51%股权转由国务院国资委属下中国宝武持有
马鞍山钢铁股份(00323.HK)公布,於5月31日,安徽省国资委与中国宝武签署协议。根据协议,当协议生效及在交割时,安徽省国资委将向中国宝武无偿划转其持有的马钢集团51%股权。马钢集团余下的49%股权将继续由安徽省国资委持有。
中国宝武由国务院国资委全资拥有。划转完成後,马钢集团的实际控制人将由安徽省国资委变更为国务院国资委,公司直接控股股东保持不变,仍为马钢集团。
除非获执行人员豁免,否则划转在交割时根据收购守则可能导致中国宝武须对公司所有股份提出强制性全面收购要约。据马钢集团告知,中国宝武已向执行人员申请豁免其根据收购守则规则对公司全部股份作出全面收购要约之责任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.